PARNELL PHARMACEUT HLDGS LTD's ticker is PARNF and the CUSIP is Q73622104. A total of 14 filers reported holding PARNELL PHARMACEUT HLDGS LTD in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $96,000 | -5.9% | 147,458 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $102,000 | -51.2% | 147,458 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $209,000 | -12.9% | 147,458 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $240,000 | -23.6% | 147,458 | 0.0% | 0.00% | -33.3% |
| Q1 2016 | $314,000 | -57.5% | 147,458 | -22.6% | 0.00% | -62.5% |
| Q4 2015 | $739,000 | -3.1% | 190,501 | -14.1% | 0.01% | -11.1% |
| Q3 2015 | $763,000 | -62.9% | 221,894 | -46.6% | 0.01% | -25.0% |
| Q2 2015 | $2,058,000 | +169.7% | 415,918 | +167.6% | 0.01% | +9.1% |
| Q1 2015 | $763,000 | -3.4% | 155,401 | -18.3% | 0.01% | -15.4% |
| Q4 2014 | $790,000 | -30.4% | 190,298 | -3.6% | 0.01% | -43.5% |
| Q3 2014 | $1,135,000 | -20.4% | 197,346 | -4.5% | 0.02% | -28.1% |
| Q2 2014 | $1,426,000 | – | 206,683 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Endurant Capital Management LP | 448,802 | $637,000 | 0.24% |
| SABBY MANAGEMENT, LLC | 369,700 | $532,000 | 0.02% |
| ATWOOD & PALMER INC | 16,900 | $24,000 | 0.00% |
| Alyeska Investment Group, L.P. | 147,458 | $209,000 | 0.00% |
| AlphaMark Advisors, LLC | 400 | $1,000 | 0.00% |
| BLACKROCK ADVISORS LLC | 562,896 | $799,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 24,300 | $35,000 | 0.00% |
| Cambridge Investment Research Advisors, Inc. | 10,000 | $14,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 690 | $1,000 | 0.00% |
| Creative Planning | 5,500 | $8,000 | 0.00% |